Weghofer Andrea, Himaya Eric, Kushnir Vitaly A, Barad David H, Lazzaroni-Tealdi Emanuela, Yu Yao, Wu Yan-Guang, Gleicher Norbert
Center for Human Reproduction, New York, NY, USA.
Department of Obstetrics and Gynecology, Medical University Vienna, Vienna, Austria.
Reprod Biol Endocrinol. 2015 Apr 11;13:29. doi: 10.1186/s12958-015-0020-5.
In successful reproduction, endocrine and immune systems closely interact. We here attempt to further elucidate the relationship between androgen levels, systemic activation of the immune system and reproductive success in infertile women, utilizing 2 distinct infertile patient cohorts.
In Group 1, we investigated 322 women (ages 38.6+/-5.4 years) at initial presentation; in Group 2 125 women undergoing in vitro fertilization (169 IVF cycles, ages 38.9+/-5.5 years). In Group 1, we assessed androgens and an immune panel, previously demonstrated to discriminate between activated quiescent immune systems; in Group 2, utilizing the same immune panel, we investigated whether immune system activation relates to embryo quality in IVF cycles.
No individual immune test within the immune panel was associated with androgen levels. The total/free testosterone ratio (TT/FT) was, however, significantly associated with presence of gammopathies (in IgG, IgM, IgA, IgE; P=0.026). Surprisingly, immune system activation was associated with significantly improved embryo quality (P=0.008), a finding persistent after adjustment for age and repeat IVF cycles (P=0.006).
Association of immune system activation with improved embryo quality concurs with previously reported immune activation in association with normal functional ovarian reserve (FOR) and normal androgen levels, while, counter intuitively, hypoandrogenism and low FOR are associated with lack of immune system activation. Mild immune system activation, therefore, likely appears essential for establishment of pregnancy, and may be regulated by androgens.
在成功的生殖过程中,内分泌系统和免疫系统密切相互作用。我们在此尝试利用两个不同的不孕患者队列,进一步阐明雄激素水平、免疫系统的全身激活与不孕女性生殖成功之间的关系。
在第1组中,我们在初次就诊时调查了322名女性(年龄38.6±5.4岁);在第2组中,125名接受体外受精的女性(169个体外受精周期,年龄38.9±5.5岁)。在第1组中,我们评估了雄激素和一组免疫指标,这些指标先前已被证明可区分激活的和静止的免疫系统;在第2组中,利用相同的免疫指标,我们研究了免疫系统激活是否与体外受精周期中的胚胎质量相关。
免疫指标中的任何一项个体免疫检测均与雄激素水平无关。然而,总睾酮/游离睾酮比值(TT/FT)与丙种球蛋白病(IgG、IgM、IgA、IgE;P = 0.026)的存在显著相关。令人惊讶的是,免疫系统激活与胚胎质量显著改善相关(P = 0.008),在调整年龄和重复体外受精周期后这一发现仍然存在(P = 0.006)。
免疫系统激活与胚胎质量改善之间的关联与先前报道的免疫激活与正常功能性卵巢储备(FOR)和正常雄激素水平相关一致,而与直觉相反的是,雄激素缺乏和低FOR与免疫系统激活缺乏相关。因此,轻度免疫系统激活可能对妊娠的建立至关重要,并且可能受雄激素调节。